Mandate

VINGE ADVISES ON OPUS GROUP’S RIGHTS ISSUE

February 13, 2015

Vinge is advising Opus Group in connection with a rights issue of approximately SEK 150 million. The rights issue is conditional upon approval by the members at an extraordinary general meeting to be held on 10 March 2015. The board of directors will determine the terms and conditions governing the rights issue not later five days prior to the record day. A prospectus is expected to be published on 11 March 2015 and the subscription period is 17-31 March 2015.

Vinge’s team advising on the preparation of the prospectus and capital markets issues consists of responsible partner Anders Strid together with associates Daniel Lennartsson, Frida Bäckgren and Anna Hofling Johansson (tax).

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025